Actions biotechnologiques — Analyse et classements par IA
Cette page a été traduite automatiquement de l'original anglais par IA ; la version anglaise fait foi. Lire la version anglaise
Réponse Rapide
Parcourez toutes les actions biotechnologiques avec une analyse basée sur l'IA, les MoonshotScores et les objectifs de prix.
Parcourez toutes les actions biotechnologiques avec une analyse basée sur l'IA, les MoonshotScores et les objectifs de prix.
Actions Similaires dans le secteur Biotechnologie
| Société | Prix | Variation | Capitalisation boursière | MoonshotScore |
|---|---|---|---|---|
| EXEL Exelixis, Inc. | $56.20 | -2.14% | $14.1B | 98 |
| INCY Incyte Corporation | $123.28 | -2.17% | $25.0B | 98 |
| KRYS Krystal Biotech, Inc. | $345.55 | -0.73% | $10.2B | 98 |
| ARGX argenx SE | $984.04 | -1.82% | $61.2B | 97 |
| ETON Eton Pharmaceuticals, Inc. | $57.15 | -1.26% | $1.57B | 97 |
| HRMY Harmony Biosciences Holdings, Inc. | $41.10 | -1.25% | $2.39B | 97 |
| UTHR United Therapeutics Corporation | $503.86 | -0.58% | $21.4B | 97 |
| HALO Halozyme Therapeutics, Inc. | $107.00 | -0.36% | $12.7B | 96 |
| LQDA Liquidia Corporation | $67.71 | -0.21% | $6.02B | 96 |
| VRTX Vertex Pharmaceuticals Incorporated | $514.90 | +0.07% | $131B | 96 |
| LGND Ligand Pharmaceuticals Incorporated | $289.25 | +0.42% | $5.80B | 95 |
| TBPH Theravance Biopharma, Inc. | $17.02 | -0.23% | $882M | 95 |
| VCYT Veracyte, Inc. | $42.03 | -4.17% | $3.35B | 95 |
| INVA Innoviva, Inc. | $20.56 | -0.29% | $1.52B | 94 |
| REGN Regeneron Pharmaceuticals, Inc. | $793.26 | -1.78% | $81.7B | 94 |
| RIGL Rigel Pharmaceuticals, Inc. | $47.26 | -0.04% | $874M | 93 |
| TECH Bio-Techne Corporation | $72.35 | +0.37% | $11.3B | 93 |
| ADMA ADMA Biologics, Inc. | $9.30 | -0.91% | $2.16B | 92 |
| NBIX Neurocrine Biosciences, Inc. | $156.61 | +0.03% | $15.8B | 92 |
| NVO Novo Nordisk A/S | $44.01 | -1.23% | $195B | 92 |
| ZVRA Zevra Therapeutics, Inc. | $12.06 | +0.17% | $713M | 92 |
| VCEL Vericel Corporation | $37.50 | -0.98% | $1.92B | 91 |
| ASND Ascendis Pharma A/S | $261.23 | +0.16% | $16.2B | 90 |
| AUPH Aurinia Pharmaceuticals Inc. | $16.11 | -0.86% | $2.07B | 90 |
| CORT Corcept Therapeutics Incorporated | $114.92 | -0.67% | $12.4B | 90 |
| ALNY Alnylam Pharmaceuticals, Inc. | $247.51 | -4.07% | $33.1B | 89 |
| CRMD CorMedix Inc. | $7.96 | -0.06% | $624M | 88 |
| MDXG MiMedx Group, Inc. | $4.60 | -1.71% | $671M | 87 |
| ABUS Arbutus Biopharma Corporation | $5.12 | -0.97% | $1.01B | 86 |
| ARQT Arcutis Biotherapeutics, Inc. | $23.38 | -1.93% | $2.92B | 86 |
| CAI Caris Life Sciences, Inc. | $24.04 | +0.04% | $6.80B | 82 |
| RLYB Rallybio Corporation | $16.75 | -1.30% | $88.9M | 82 |
| ACAD ACADIA Pharmaceuticals Inc. | $27.74 | +0.22% | $4.75B | 80 |
| BLTE Belite Bio, Inc. | $175.07 | -4.42% | $7.02B | 80 |
| ORMP Oramed Pharmaceuticals Inc. | $4.74 | -0.38% | $194M | 78 |
| ICCC ImmuCell Corporation | $9.91 | +0.05% | $89.7M | 77 |
| PTGX Protagonist Therapeutics, Inc. | $146.75 | +1.10% | $9.44B | 77 |
| CLYM Climb Bio, Inc. | $14.32 | -4.21% | $820M | 74 |
| ELVN Enliven Therapeutics, Inc. | $56.23 | -2.12% | $4.02B | 74 |
| MBX MBX Biosciences | $60.94 | -3.13% | $2.90B | 74 |
| APGE Apogee Therapeutics, Inc. | $135.07 | — | $8.36B | 72 |
| RPRX Royalty Pharma plc | $58.75 | -3.04% | $26.0B | 72 |
| ORKA Oruka Therapeutics, Inc. | $91.65 | +0.16% | $5.53B | 71 |
| MGTX MeiraGTx Holdings plc | $12.85 | -3.09% | $1.19B | 70 |
| AMLX Amylyx Pharmaceuticals, Inc. | $32.58 | +1.54% | $3.62B | 69 |
| NWPHF Newron Pharmaceuticals S.p.A. | $20.00 | — | $416M | 68 |
| QTTB Q32 Bio Inc. | $10.93 | +1.96% | $325M | 68 |
| SLS SELLAS Life Sciences Group, Inc. | $13.49 | -3.30% | $2.51B | 68 |
| ZLDPF Zealand Pharma A/S | $46.38 | -2.66% | $3.28B | 68 |
| ALKS Alkermes plc | $46.11 | +1.56% | $7.74B | 67 |
Score IA par Stock Expert AI · Données de prix : FMP / Yahoo Finance